MedPath

PROSKI ZINCO SKIN PROTECTANT

Zinc Oxide Ointment

Approved
Approval ID

2cb7f314-beb4-e57f-e063-6394a90ad3ef

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Mar 18, 2025

Manufacturers
FDA

PHARMAMED USA INC

DUNS: 065607328

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ZINC OXIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code84289-119
Application NumberM016
Product Classification
M
Marketing Category
C200263
G
Generic Name
ZINC OXIDE
Product Specifications
Route of AdministrationTOPICAL
Effective DateMarch 18, 2025
FDA Product Classification

INGREDIENTS (5)

ZINC OXIDEActive
Quantity: 200 mg in 1 g
Code: SOI2LOH54Z
Classification: ACTIB
LIGHT MINERAL OILInactive
Code: N6K5787QVP
Classification: IACT
CETOSTEARYL ALCOHOLInactive
Code: 2DMT128M1S
Classification: IACT
WHITE PETROLATUMInactive
Code: B6E5W8RQJ4
Classification: IACT
CETETH-20Inactive
Code: I835H2IHHX
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PROSKI ZINCO SKIN PROTECTANT - FDA Drug Approval Details